Movatterモバイル変換


[0]ホーム

URL:


CN115040147A - Parkinson's disease prediction method based on 18F-FDG PET metabolic network - Google Patents

Parkinson's disease prediction method based on 18F-FDG PET metabolic network
Download PDF

Info

Publication number
CN115040147A
CN115040147ACN202210616879.7ACN202210616879ACN115040147ACN 115040147 ACN115040147 ACN 115040147ACN 202210616879 ACN202210616879 ACN 202210616879ACN 115040147 ACN115040147 ACN 115040147A
Authority
CN
China
Prior art keywords
metabolic
parkinson
metabolic network
fdg pet
method based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210616879.7A
Other languages
Chinese (zh)
Inventor
彭莉玲
高欣
李伟凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Universal Medical Imaging Diagnosis Center Co ltd
Original Assignee
Shanghai Universal Medical Imaging Diagnosis Center Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Universal Medical Imaging Diagnosis Center Co ltdfiledCriticalShanghai Universal Medical Imaging Diagnosis Center Co ltd
Priority to CN202210616879.7ApriorityCriticalpatent/CN115040147A/en
Publication of CN115040147ApublicationCriticalpatent/CN115040147A/en
Pendinglegal-statusCriticalCurrent

Links

Images

Classifications

Landscapes

Abstract

The invention discloses a Parkinson's disease prediction method based on an 18F-FDG PET metabolic network, and belongs to the technical field of preventive medicine. The method comprises the steps of collecting and processing brain CT data of an object, constructing a metabolic network to obtain links and graph attribute, fusing different connection information based on the multi-core SVM, training and classifying, establishing a PD diagnosis prediction model, and predicting by using the trained model. Most consensus junctions in the frontal, parietal and occipital regions of PD patients were found to decrease, while frontal, temporal and subcortical regions increased based on metabolic networks. These abnormal functional network measurements show ideal classification performance in identifying PD individuals from HC individuals, with accuracy rates as high as 91.84%.

Description

Parkinson's disease prediction method based on 18F-FDG PET metabolic network
Technical Field
The invention belongs to the technical field of preventive medicine, and particularly relates to a Parkinson's disease prediction method based on an 18F-FDG PET metabolic network.
Background
Currently, about 620 million people are affected worldwide, and Parkinson's Disease (PD) is the second most common neurodegenerative disorder, the prevalence of which may increase in the next decades (Vos et al, 2017). Unfortunately, the diagnosis of PD and disease severity assessment are primarily assessed through clinical examination and follow-up. An effective method for predicting the follow-up diagnosis is urgently needed to improve the diagnostic performance of PD. Positron emission tomography using 18F-fluorodeoxyglucose (18F-FDG PET) is a functional neuroimaging technique that can measure metabolic abnormalities of PD at the system level. The existing PET-based method directly utilizes PET data for diagnosis, usually fails to consider the metabolic interaction among regions, may lose the relevant information about metabolic topology or individual difference in the network, and greatly reduces the diagnosis performance.
Through retrieval, the Chinese invention patent is as follows: the application discloses a Parkinson prediction method based on nuclear magnetic resonance (with the application number of CN201810983951.3 and the application date of 2018.08.27), which comprises the following steps: acquiring a craniocerebral nuclear magnetic resonance image to be diagnosed; processing the craniocerebral nuclear magnetic resonance image to be diagnosed to obtain a white matter image to be diagnosed; and predicting the Parkinson according to the white matter image to be diagnosed based on a pre-trained Parkinson prediction model. Correspondingly, the invention also discloses a Parkinson prediction system based on nuclear magnetic resonance, a computer readable storage medium and terminal equipment. By adopting the technical scheme of the invention, the prediction of the Parkinson can be realized, and the prediction accuracy is improved. However, this application has a disadvantage that the judgment is performed only by morphological analysis based on a white matter image of the brain, which is not comprehensive enough to cause a problem of low recognition rate.
Disclosure of Invention
1. Technical problem to be solved by the invention
The invention aims to solve the problems that the existing PET-based method directly utilizes PET data to diagnose, usually fails to consider the metabolic interaction among regions, possibly loses relevant information about metabolic topology or individual difference in a network, and greatly reduces the diagnosis performance.
2. Technical scheme
In order to achieve the purpose, the technical scheme provided by the invention is as follows:
the Parkinson's disease prediction method based on the 18F-FDG PET metabolic network comprises the steps of collecting and processing brain CT data of an object, constructing the metabolic network to obtain links and graph attributes, fusing, training and classifying different connection information based on the multi-core SVM, establishing a PD diagnosis prediction model, and predicting by using the trained model.
Preferably, the method specifically comprises the following steps:
s100, data acquisition;
s200, preprocessing data;
s300, constructing a metabolic network;
s400, extracting features, and acquiring link and graph theory attributes;
s500, establishing a PD diagnosis prediction model;
s600, predicting a result.
Preferably, the data acquisition of step S100 is to build a 3-dimensional (3D) model after scanning the object by using a PET/CT scanner, and reconstruct the image by using an ordered subset expectation maximization algorithm with 6 iterations and 6 subset methods.
Preferably, the data preprocessing of step S200 is specifically data preprocessing by using SPM-based toolkit to normalize the single 18F-FDG PET image volume space to a standard stereotactic Montreal Neurology Institute (MNI) space with linear and non-linear 3D transforms, and to apply an Automatic Anatomical Labeling (AAL) atlas to segment the cerebral cortex into 90 regions.
Preferably, the metabolic network construction of step S300 is specifically to use JS divergence to capture statistical relationships of brain glucose metabolic similarities in any 2 regions, and further to depict individual metabolic connections, use 90 ROIs from AAL atlas to represent brain nodes to depict individual metabolic networks;
extracting voxel intensities in each ROI and estimating a Probability Density Function (PDF) of the corresponding ROI by using a kernel density estimation; metabolic networking was obtained according to Jensen-Shannon (JS) divergence as follows:
JSs(P||Q)=exp(-DJS (P||Q));
wherein,
Figure BDA0003674657320000031
p and Q represent probability density functions of different ROIs, M is 0.5 (P + Q), DkL (. |. cndot.) represents KL divergence.
Preferably, the step S400 is specifically to extract global and local attributes based on the constructed metabolic network, where the global attributes include a clustering coefficient (C _ p), a feature path length (L _ p), a normalized clustering coefficient (γ), a normalized feature path length (λ), a small world (σ), a global efficiency (E _ global), and a modularization score (Q); the local attributes include degree centrality, node efficiency, intermediary centrality, shortest path length, and node clustering coefficients.
Preferably, the step S500 is specifically to fuse, train and classify different connection information based on the multi-core SVM, sparsify the network under different sparse thresholds (0.02-0.5, step length is 0.01) to obtain a sum of 49 values of the attribute of the corresponding node under the sparse threshold, and then train the classifier by using the sum of 49 values of each node (area under the curve, AUC) as the input of the attribute to establish the PD diagnosis prediction model.
3. Advantageous effects
Compared with the prior art, the technical scheme provided by the invention has the following beneficial effects:
the Parkinson's disease prediction method based on the 18F-FDG PET metabolic network comprises the steps of collecting and processing brain CT data of an object, constructing the metabolic network to obtain links and graph attributes, fusing, training and classifying different connection information based on the multi-core SVM, establishing a PD diagnosis prediction model, and predicting by using the trained model. Most consensus junctions in the frontal, parietal and occipital regions of PD patients were found to decrease, while frontal, temporal and subcortical regions increased based on metabolic networks. These abnormal functional network measurements show ideal classification performance in identifying PD individuals from HC individuals, with accuracy as high as 91.84%.
Drawings
FIG. 1 is a flow chart of a method of the present invention;
FIG. 2 is a diagram of the consensus connection of example 2.
Detailed Description
In order to make the technical solutions of the present application better understood by those skilled in the art, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the drawings in the embodiments of the present application, and it is obvious that the described embodiments are only some embodiments of the present application, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present application will be described in detail below with reference to the embodiments with reference to the attached drawings.
Example 1
Referring to fig. 1, according to the parkinson's disease prediction method based on the 18F-FDG PET metabolic network, brain CT data of an object is collected and processed, after metabolic network acquisition links and graph attribute are constructed, different connection information is fused, trained and classified based on the multi-core SVM, a PD diagnosis prediction model is established, and the trained model is used for prediction. Most consensus junctions in the frontal, parietal and occipital regions of PD patients were found to decrease, while frontal, temporal and subcortical regions increased based on metabolic networks. These abnormal functional network measurements show ideal classification performance in identifying PD individuals from HC individuals, with accuracy as high as 91.84%.
The method specifically comprises the following steps:
s100, data acquisition;
s200, preprocessing data;
s300, constructing a metabolic network;
s400, extracting features, and acquiring link and graph theory attributes;
s500, establishing a PD diagnosis prediction model;
and S600, predicting a result.
The data acquisition in step S100 is specifically to use a PET/CT scanner to scan an object, establish a 3-dimensional (3D) model, and reconstruct an image by using an ordered subset expectation-maximization algorithm with 6 iterations and 6 subset methods.
The data preprocessing of step S200 is specifically to utilize SPM-based toolkit to perform data preprocessing, normalize the single 18F-FDG PET image volume space to a standard stereotactic Montreal Neurology Institute (MNI) space with linear and nonlinear 3D transforms, and apply an Automatic Anatomical Labeling (AAL) atlas to segment the cerebral cortex into 90 regions.
The metabolic network construction of the step S300 is specifically to use JS divergence to capture statistical relationships of brain glucose metabolic similarity in any 2 regions, and further to depict individual metabolic connections to use 90 ROIs from the AAL map set to represent brain nodes so as to depict individual metabolic networks;
extracting voxel intensities in each ROI and estimating a Probability Density Function (PDF) of the corresponding ROI by using a kernel density estimation; metabolic networking was obtained according to Jensen-Shannon (JS) divergence as follows:
JSs(P||Q)=exp(-DJS (P||Q));
wherein,
Figure BDA0003674657320000051
p and Q represent probability density functions of different ROIs, M0.5 × (P + Q), DkL (. |. cndot.) represents KL divergence.
The step S400 is specifically to extract global and local attributes based on the constructed metabolic network, where the global attributes include a clustering coefficient (C _ p), a feature path length (L _ p), a normalized clustering coefficient (γ), a normalized feature path length (λ), a small world (σ), a global efficiency (E _ global), and a modularization score (Q); the local attributes include degree centrality, node efficiency, intermediary centrality, shortest path length, and node clustering coefficients.
The step S500 is specifically to fuse, train and classify different connection information based on the multi-core SVM, sparsify the network under different sparse thresholds (0.02-0.5, step length is 0.01), obtain the sum of 49 values of the corresponding node attribute under the sparse threshold, train the classifier using the sum of 49 values of each node (area under the curve, AUC) as the input of the attribute, and establish the PD diagnosis prediction model.
Example 2
A total of 49 patients (33 male and 16 female participants, 53.94 ± 11.16 years) diagnosed as idiopathic PD according to the international association of parkinsonism and dyskinesias (MDS) diagnostic criteria and continuously enrolled in the study during months 1 and 12 in 2018 to 2019 using an 18F-FDG PET scan. Patients with a history of head injury, stroke, intracranial surgery, psychiatric disease, and substance use disorder were excluded. Detailed clinical participant information is presented in table 1. In addition, 49 HC's of matched age, education, and gender distribution were enrolled randomly to obtain normative data. None of the HCs has a history of cognitive disorders, psychiatric disorders, central nervous system disorders or head injuries. All participants provided written informed consent.
TABLE 1 demographic and clinical characteristics of PD patients and HC
Figure BDA0003674657320000061
Figure BDA0003674657320000071
A single 18F-FDG PET image volume space is normalized to a standard MNI space with linear and non-linear 3D transforms. To facilitate comparisons among all participants, a de-baseline operation was performed. After that time, the user can use the device,an Automatic Anatomical Labeling (AAL) map was applied to segment the cerebral cortex into 90 regions (45 regions per hemisphere without cerebellum). After the corresponding image is acquired, the JSSE (JSs (P | | Q) ═ exp (-D) is usedJS (P | | Q))) to construct a metabolic network. The constructed metabolic network further extracts global and local graph theory attributes, wherein the global graph theory attributes are as follows:
TABLE 2 Global graph attribute of the constructed metabolic network
Figure BDA0003674657320000072
Figure BDA0003674657320000081
Ar ,assortativity;Cp ,clustering coefficient;Eglobal ,global efficiency;Elocal ,local efficiency;Hr,hierarchy;Lp ,characteristic path length;NC,normal control;PD,Parkinson's disease;Q,modularity score;Sr ,synchronization;γ,normalized clustering coefficient;λ,normalized characteristic path length;σ,small-world.*p-value<0.05.
The consensus junction was obtained as in FIG. 2:
finally, the classification results by using various modes and multiple cores are as follows: it can be seen that the PD classification diagnosis can be effectively performed.
TABLE 3 accuracy of classification
Figure BDA0003674657320000082
Figure BDA0003674657320000091
Note:C+G+N methods are significantly superior to Connection,Global,and Nodal under 95%confidence interval with p-value equals to 0.0482,4×10-6 and0.0115 respectively。
The above embodiments only express a certain implementation manner of the present invention, and the description is specific and detailed, but not to be understood as limiting the scope of the present invention; it should be noted that, for those skilled in the art, without departing from the concept of the present invention, several variations and modifications can be made, which are within the protection scope of the present invention; therefore, the protection scope of the present patent should be subject to the appended claims.

Claims (7)

1. A Parkinson's disease prediction method based on an 18F-FDG PET metabolic network is characterized by comprising the following steps: collecting and processing brain CT data of an object, constructing a metabolic network to obtain links and graph attribute, fusing different connection information based on the multi-core SVM, training and classifying, establishing a PD diagnosis prediction model, and predicting by using the trained model.
2. The method for predicting the Parkinson's disease based on the 18F-FDG PET metabolic network according to claim 1, which is characterized by comprising the following steps:
s100, data acquisition;
s200, preprocessing data;
s300, constructing a metabolic network;
s400, extracting features, and acquiring link and graph theory attributes;
s500, establishing a PD diagnosis prediction model;
s600, predicting a result.
3. The Parkinson's disease prediction method based on the 18F-FDG PET metabolic network according to claim 2, which is characterized in that: the data acquisition of step S100 is specifically to use a PET/CT scanner to scan an object, then build a 3-dimensional (3D) model, and use an ordered subset expectation-maximization algorithm with 6 iterations and 6 subset methods to reconstruct an image.
4. The Parkinson's disease prediction method based on the 18F-FDG PET metabolic network according to claim 2, which is characterized in that: the data preprocessing of step S200 is specifically to utilize SPM-based toolkit to perform data preprocessing, normalize the single 18F-FDG PET image volume space to a standard stereotactic Montreal Neurology Institute (MNI) space with linear and nonlinear 3D transforms, and apply an Automatic Anatomical Labeling (AAL) atlas to segment the cerebral cortex into 90 regions.
5. The Parkinson's disease prediction method based on the 18F-FDG PET metabolic network according to claim 2, which is characterized in that: the metabolic network construction of the step S300 is specifically to use JS divergence to capture statistical relationships of brain glucose metabolic similarity in any 2 regions, and further to depict individual metabolic connections to use 90 ROIs from the AAL map set to represent brain nodes so as to depict individual metabolic networks;
extracting voxel intensities in each ROI and estimating a Probability Density Function (PDF) of the corresponding ROI by using a kernel density estimation; metabolic networking was obtained according to Jensen-Shannon (JS) divergence as follows:
JSs(P||Q)=exp(-DJS (P||Q));
wherein,
Figure FDA0003674657310000021
p and Q represent probability density functions of different ROIs, M0.5 × (P + Q), DKL (. |. cndot.) represents KL divergence.
6. The Parkinson's disease prediction method based on the 18F-FDG PET metabolic network according to claim 2, which is characterized in that: the step S400 is specifically to extract global and local attributes based on the constructed metabolic network, where the global attributes include a clustering coefficient (C _ p), a feature path length (L _ p), a normalized clustering coefficient (γ), a normalized feature path length (λ), a small world (σ), a global efficiency (E _ global), and a modularization score (Q); the local attributes include degree centrality, node efficiency, intermediary centrality, shortest path length, and node clustering coefficients.
7. The Parkinson's disease prediction method based on the 18F-FDG PET metabolic network according to claim 2, characterized in that: the step S500 is specifically to fuse, train and classify different connection information based on the multi-core SVM, sparsify the network under different sparse thresholds (0.02-0.5, step length is 0.01), obtain the sum of 49 values of the corresponding node attribute under the sparse threshold, train the classifier using the sum of 49 values of each node (area under the curve, AUC) as the input of the attribute, and establish the PD diagnosis prediction model.
CN202210616879.7A2022-06-012022-06-01Parkinson's disease prediction method based on 18F-FDG PET metabolic networkPendingCN115040147A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202210616879.7ACN115040147A (en)2022-06-012022-06-01Parkinson's disease prediction method based on 18F-FDG PET metabolic network

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202210616879.7ACN115040147A (en)2022-06-012022-06-01Parkinson's disease prediction method based on 18F-FDG PET metabolic network

Publications (1)

Publication NumberPublication Date
CN115040147Atrue CN115040147A (en)2022-09-13

Family

ID=83159899

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202210616879.7APendingCN115040147A (en)2022-06-012022-06-01Parkinson's disease prediction method based on 18F-FDG PET metabolic network

Country Status (1)

CountryLink
CN (1)CN115040147A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN116895360A (en)*2023-09-112023-10-17首都医科大学宣武医院Drug curative effect prediction method, system, terminal and storage medium applied to MCI patient

Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20050215889A1 (en)*2004-03-292005-09-29The Board of Supervisory of Louisiana State UniversityMethods for using pet measured metabolism to determine cognitive impairment
CN109222902A (en)*2018-08-272019-01-18上海铱硙医疗科技有限公司Parkinson's prediction technique, system, storage medium and equipment based on nuclear magnetic resonance
CN112365464A (en)*2020-11-092021-02-12成都信息工程大学GAN-based medical image lesion area weak supervision positioning method
CN112353381A (en)*2020-11-242021-02-12杭州冉曼智能科技有限公司Alzheimer's disease comprehensive diagnosis system based on multi-modal brain images
CN113303782A (en)*2021-05-202021-08-27南京伯睿生命科学研究院有限公司Alzheimer disease SVM classification model construction method based on nuclear magnetic resonance spectrum
CN114533102A (en)*2022-01-282022-05-27深圳先进技术研究院Method for investigating individual-level general metabolic abnormality by using general SUV image

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20050215889A1 (en)*2004-03-292005-09-29The Board of Supervisory of Louisiana State UniversityMethods for using pet measured metabolism to determine cognitive impairment
CN109222902A (en)*2018-08-272019-01-18上海铱硙医疗科技有限公司Parkinson's prediction technique, system, storage medium and equipment based on nuclear magnetic resonance
CN112365464A (en)*2020-11-092021-02-12成都信息工程大学GAN-based medical image lesion area weak supervision positioning method
CN112353381A (en)*2020-11-242021-02-12杭州冉曼智能科技有限公司Alzheimer's disease comprehensive diagnosis system based on multi-modal brain images
CN113303782A (en)*2021-05-202021-08-27南京伯睿生命科学研究院有限公司Alzheimer disease SVM classification model construction method based on nuclear magnetic resonance spectrum
CN114533102A (en)*2022-01-282022-05-27深圳先进技术研究院Method for investigating individual-level general metabolic abnormality by using general SUV image

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRAJKOVIC L, KOSTIC V, SOBIC-SARANOVIC D, STEFANOVA E, JECMENICA-LUKIC M, JESIC A, STOJILJKOVIC M, ODALOVIC S, GALLIVANONE F, CAST: "The utility of FDG-PET in the differential diagnosis of Parkinsonism"*
ZHAO Y, YAO ZJ, ZHENG WH, YANG J, DING ZJ, LI M, LU SF: "Predicting MCI Progression with Individual Metabolic Network Based on Longitudinal FDG-PET"*
吴晓霞;于心悦;黄寅;刘佩芳;: "基于网络的脑卒中血液代谢标志物分析"*
许鹏,王兵,方刚,石晓龙,刘文斌: "基于可变剪接紊乱的乳腺癌亚型预测分析"*
邱轶慧,聂坤,高玉元,王婉怡,许齐欢,张玉虎,王丽敏,王丽娟: "基于DTI的早中晚期帕金森病脑白质网络拓扑属性改变研究"*
黄克敏,冯彦林,贺小红,温广华,梁伟棠,余丰文,刘德军,袁建伟,杨明: "Philips GEMINI PET/CT 五种常规图像重建算法图像质量比较"*

Cited By (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN116895360A (en)*2023-09-112023-10-17首都医科大学宣武医院Drug curative effect prediction method, system, terminal and storage medium applied to MCI patient
CN116895360B (en)*2023-09-112023-12-05首都医科大学宣武医院 A drug efficacy prediction method, system, terminal and storage medium for MCI patients

Similar Documents

PublicationPublication DateTitle
US11049243B2 (en)Target detection in latent space
Yiğit et al.Applying deep learning models to structural MRI for stage prediction of Alzheimer's disease
Devika et al.Outlier-based autism detection using longitudinal structural MRI
CN114595715B (en) A multi-timescale-based classification method for autism functional magnetic resonance imaging signals
Zhao et al.Constructing multi-view high-order functional connectivity networks for diagnosis of autism spectrum disorder
Devika et al.A machine learning approach for diagnosing neurological disorders using longitudinal resting-state fMRI
GuanApplication of logistic regression algorithm in the diagnosis of expression disorder in Parkinson's disease
Afshar et al.Age prediction based on brain mri images using extreme learning machine
Ebrahimzadeh et al.Towards an automatic diagnosis system for lumbar disc herniation: the significance of local subset feature selection
CN115040147A (en)Parkinson&#39;s disease prediction method based on 18F-FDG PET metabolic network
Singh et al.Prediction of pain intensity using multimedia data
Minaee et al.Identifying mild traumatic brain injury patients from MR images using bag of visual words
CN111325268A (en)Image classification method and device based on multi-level feature representation and integrated learning
Mo et al.SFF-DA: Spatiotemporal feature fusion for nonintrusively detecting anxiety
Tobin et al.Using a patient image archive to diagnose retinopathy
Arya et al.Intelligence quotient classification from human MRI brain images using convolutional neural network
CN118334431A (en)Alzheimer&#39;s disease classification method and system based on high-order attention and graph convolution network
Dhamale et al.Fusion of features: a technique to improve autism spectrum disorder detection using brain MRI images
Aghaei et al.Epileptic seizure detection based on video and EEG recordings
MahapatraMultimodal generalized zero shot learning for gleason grading using self-supervised learning
Hsieh et al.Behavior score-embedded brain encoder network for improved classification of Alzheimer disease using resting state fMRI
Zhang et al.Comparison of Neural Networks' Performance in Early Screening of Autism Spectrum Disorders Under Two MRI Principles
Sri et al.A relative analysis of machine learning based approaches to detect human pain intensity using facial expressions
Vasu et al.A survey on bipolar disorder classification methodologies using machine learning
Wang et al.Adaptive Multiview Community-Preserved Graph Convolutional Network for Multiatlas-Based Functional Connectivity Analysis

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20220913

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp